Medical Devices M&A Deals H1 2026 – Top Themes: Strategic Intelligence
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
This report analyzes the disruptive themes that have driven M&A activity in H1 2026 in the Medical Devices Sector
Scope
This report provides an overview of merger and acquisition activity globally in H1 2026 in Medical Devices Sector
It identifies the themes driving most notable to deals announced in H1 2026 in the Medical Devices Sector
Key Highlights
The global medical devices market witnessed deals worth $67 billion in H1 2026, an increase of 150% compared to H1 2025. The sector recorded deal value worth $48 billion mega-deals (defined as any deal valued at more than $1 billion), an increase of 175% compared to H1 2025.
Reasons to Buy
Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
In this report we have listed down the most notable deals in medical devices sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.
Merck KGaA
Danaher Corp
Amplifon SpA
Jardine Matheson Holdings Ltd
Boston Scientific Corp
American Industrial Partners
Apollo Funds
Astorg Partners
Roche Holding AG
Penumbra Inc
Bio-Techne Corp
Masimo Corp
GN Store Nord
I-MED Radiology Network Ltd
MiRus LLC
Avanos Medical Inc
McKesson Medical-Surgical Solutions
Thermo Fisher Scientific
PathAI Inc
Table of Contents
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Medical Devices reports